[Novel advances following the integration of Baveno VII consensus definitions for the non-invasive testing of portal hypertension]. [PDF]
Chen JL, Yang CQ.
europepmc +1 more source
Clinical characteristics and risk factors for primary Sjögren's syndrome complicated with pulmonary arterial hypertension. [PDF]
Chen Z, Tian J, Ouyang R.
europepmc +1 more source
[Non-invasive evaluation and prediction of portal hypertension: focusing on disease progression and outcome]. [PDF]
Xu PS, Wang MC, Chen JJ, Wang HY.
europepmc +1 more source
[Clinical outcomes of small-size grafts in auxiliary liver transplantation for the treatment of portal hypertension]. [PDF]
Ju HF +9 more
europepmc +1 more source
[NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report]. [PDF]
Yan XD, Chen YY, Tao L.
europepmc +1 more source
[Research progress on early-stage primary biliary cholangitis accompanied by portal hypertension]. [PDF]
Ma L +5 more
europepmc +1 more source
[Rosa laevigata Michx. inhibits pulmonary arterial smooth muscle cell proliferation in hypertension by modulating the Src-AKT1 axis]. [PDF]
Yang Z +6 more
europepmc +1 more source
[Evaluation of the efficacy of the Baveno VI criteria in diagnosing clinically significant portal hypertension under different etiologic control statuses]. [PDF]
Fang SY +6 more
europepmc +1 more source
[Idiopathic portal hypertension: a case report]. [PDF]
Zhao BT, Wang Y, Jiang C, Xin YN.
europepmc +1 more source
[Research progress on bioinformatics in pulmonary arterial hypertension]. [PDF]
Peng W, Zhang ZY, Xiao YB.
europepmc +1 more source

